What is he best known for?
The fields of study he is best known for:
His primary areas of study are Biochemistry, Cell biology, Phospholipase C, Molecular biology and Signal transduction.
His work on Cell biology is being expanded to include thematically relevant topics such as Inositol.
His studies in Phospholipase C integrate themes in fields like Phospholipase and Isozyme.
Pann-Ghill Suh has included themes like Cell culture, Platelet-derived growth factor receptor, Complementary DNA, SH3 domain and Cell cycle in his Molecular biology study.
His research integrates issues of Jurkat cells, Peptide, Protein kinase A and Transcription factor in his study of Signal transduction.
His Mesenchymal stem cell differentiation research is multidisciplinary, relying on both Endocrinology and Internal medicine.
His most cited work include:
- Studies of inositol phospholipid-specific phospholipase C. (785 citations)
- Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro (759 citations)
- Multiple roles of phosphoinositide-specific phospholipase C isozymes. (371 citations)
What are the main themes of his work throughout his whole career to date?
Pann-Ghill Suh mostly deals with Cell biology, Phospholipase C, Biochemistry, Molecular biology and Internal medicine.
Pann-Ghill Suh usually deals with Cell biology and limits it to topics linked to Receptor and PDZ domain.
His study in Phospholipase C is interdisciplinary in nature, drawing from both Phospholipase, Amino acid, Isozyme and Pleckstrin homology domain.
The study incorporates disciplines such as Apoptosis, Complementary DNA, Gene, Monoclonal antibody and MAPK/ERK pathway in addition to Molecular biology.
The study of Internal medicine is intertwined with the study of Endocrinology in a number of ways.
His biological study spans a wide range of topics, including Cancer research and Cellular differentiation.
He most often published in these fields:
- Cell biology (48.76%)
- Phospholipase C (28.22%)
- Biochemistry (25.74%)
What were the highlights of his more recent work (between 2014-2021)?
- Cell biology (48.76%)
- Signal transduction (19.06%)
- Internal medicine (20.54%)
In recent papers he was focusing on the following fields of study:
Pann-Ghill Suh mainly investigates Cell biology, Signal transduction, Internal medicine, Neuroscience and Endocrinology.
His studies deal with areas such as Phospholipase, Biochemistry and Cellular differentiation as well as Cell biology.
His Signal transduction research includes themes of Neural development, Regulation of gene expression and Cancer research.
Pann-Ghill Suh combines subjects such as Mitochondrion and Oncology with his study of Internal medicine.
Pann-Ghill Suh works mostly in the field of Endocrinology, limiting it down to topics relating to Autophagy and, in certain cases, Fatty liver.
Pann-Ghill Suh has researched Phospholipase C in several fields, including Isozyme and p38 mitogen-activated protein kinases.
Between 2014 and 2021, his most popular works were:
- Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. (125 citations)
- Phosphoinositide-specific phospholipase C in health and disease (67 citations)
- Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1 (66 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Cell biology, Signal transduction, Cellular differentiation, Endocrinology and Internal medicine.
His Cell biology study frequently links to other fields, such as Biochemistry.
His Signal transduction research integrates issues from Phospholipase, Regulation of gene expression and Cancer research.
His Phospholipase study integrates concerns from other disciplines, such as Alternative splicing, Isozyme and Function.
Pann-Ghill Suh interconnects Myeloid, Cyclin D3, Myocyte, Cell cycle and C2C12 in the investigation of issues within Cellular differentiation.
His study in the field of Skeletal muscle, Secretory protein, Ezetimibe and Sterol regulatory element-binding protein 2 also crosses realms of Annexin A1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
